PL 37

Drug Profile

PL 37

Alternative Names: Debio 0827; PL-37

Latest Information Update: 11 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pharmaleads
  • Class Non-opioid analgesics; Small molecules
  • Mechanism of Action Aminopeptidase inhibitors; Neprilysin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Neuropathic pain
  • Preclinical Cancer pain; Pain

Most Recent Events

  • 05 May 2017 Preclinical trials in Cancer pain in France (IV), before April 2017
  • 05 May 2017 Preclinical trials in Pain in France (PO), before April 2017
  • 28 Sep 2015 Phase-II clinical trials in Neuropathic pain (in patients with diabetes mellitus) in France (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top